Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329388 · ClinicalTrials.gov registry record · Phase 1
Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns
A Phase 1 study of Child Development and Body Weight, sponsored by TruHeight Vitamins.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06329388: Completed Phase 1 study of Child Development and Body Weight, sponsored by TruHeight Vitamins.
NCT06329388 is a Phase 1 study of Child Development and Body Weight that has completed, run by TruHeight Vitamins. The registered enrollment target is 32 participants, below the 1,092-participant average among 32 other Child Development trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06329388, a Phase 1 study of Child Development and Body Weight, has completed, sponsored by TruHeight Vitamins.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of type X collagen concentration in urine, height via a stadiometer, and body composition using an INBODY device.
Primary Outcome
The primary measure is the difference in children's height measured by a stadiometer from baseline to the end of the study at six months.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT TruHeight Growth Protein Shake
Study Locations (1)
California
- SF Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2023-08-11 |
| Phase | Phase 1 |
What the finished NCT06329388 record still lists
NCT06329388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,092-participant average among 32 other Child Development trials with a reported enrollment target (97% lower).
The record links to 6 conditions, with Child Development appearing as the primary indexed condition, and to 1 intervention - of which TruHeight Growth Protein Shake is the first listed.
NCT06329388 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06329388 about?
NCT06329388 is a clinical study titled "Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns". This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of ty...
What is the current status of trial NCT06329388?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2023-01-18. Estimated completion is 2023-08-11.
What conditions does trial NCT06329388 study?
This clinical trial studies the following conditions: Child Development, Body Weight, Growth Disorders, Dietary Exposure, Bone Development Abnormal.
What interventions are being tested in trial NCT06329388?
The interventions under investigation include: TruHeight Growth Protein Shake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06329388?
This trial is sponsored by TruHeight Vitamins, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329388 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06329388's enrollment target sits among peer trials
32 30th of 32 higher than 3 of 32 other Child Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
RECRUITING · Phase 1
-
Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal
COMPLETED · Phase 1
-
Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
COMPLETED · Phase 1
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
Interventions in Mathematics and Cognitive Skills
RECRUITING · NA
-
In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI